A detailed history of Ontario Teachers Pension Plan Board transactions in Exelixis, Inc. stock. As of the latest transaction made, Ontario Teachers Pension Plan Board holds 35,823 shares of EXEL stock, worth $1.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
35,823
Previous 122,340 70.72%
Holding current value
$1.19 Million
Previous $2.75 Million 66.19%
% of portfolio
0.01%
Previous 0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$21.96 - $27.6 $1.9 Million - $2.39 Million
-86,517 Reduced 70.72%
35,823 $929,000
Q2 2024

Aug 09, 2024

SELL
$20.34 - $23.73 $1.1 Million - $1.29 Million
-54,153 Reduced 30.68%
122,340 $2.75 Million
Q1 2024

May 10, 2024

SELL
$20.17 - $23.93 $1.26 Million - $1.5 Million
-62,647 Reduced 26.2%
176,493 $4.19 Million
Q4 2023

Feb 09, 2024

BUY
$19.25 - $24.13 $544,486 - $682,517
28,285 Added 13.41%
239,140 $5.74 Million
Q3 2023

Nov 13, 2023

BUY
$19.04 - $22.74 $3.31 Million - $3.96 Million
174,045 Added 472.82%
210,855 $4.61 Million
Q2 2023

Aug 11, 2023

BUY
$18.17 - $20.48 $668,837 - $753,868
36,810 New
36,810 $703,000
Q1 2023

May 12, 2023

BUY
$16.3 - $19.41 $53,464 - $63,664
3,280 Added 5.31%
65,070 $1.26 Million
Q4 2022

Feb 10, 2023

BUY
$14.96 - $17.39 $197,098 - $229,113
13,175 Added 27.1%
61,790 $991,000
Q3 2022

Nov 10, 2022

SELL
$15.68 - $22.27 $307,986 - $437,427
-19,642 Reduced 28.78%
48,615 $762,000
Q2 2022

Aug 12, 2022

BUY
$17.44 - $23.16 $234,812 - $311,826
13,464 Added 24.57%
68,257 $1.42 Million
Q1 2022

May 13, 2022

BUY
$17.03 - $22.67 $933,124 - $1.24 Million
54,793 New
54,793 $1.24 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Ontario Teachers Pension Plan Board Portfolio

Follow Ontario Teachers Pension Plan Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ontario Teachers Pension Plan Board, based on Form 13F filings with the SEC.

News

Stay updated on Ontario Teachers Pension Plan Board with notifications on news.